• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个受v-src下调的新基因的分离

Isolation of a novel gene down-regulated by v-src.

作者信息

Pan J, Nakanishi K, Yutsudo M, Inoue H, Li Q, Oka K, Yoshioka N, Hakura A

机构信息

Department of Tumor Virology, Research Institute for Microbial Diseases, Osaka University, Japan.

出版信息

FEBS Lett. 1996 Mar 25;383(1-2):21-5. doi: 10.1016/0014-5793(96)00210-4.

DOI:10.1016/0014-5793(96)00210-4
PMID:8612783
Abstract

We have isolated a novel gene which was expressed in normal rat cells, but completely suppressed in cells transformed by v-src. The molecularly cloned cDNA was about 1.8 kb in size, containing an open reading frame composed of 464 amino acid residues. DNA sequence analysis showed that there was no corresponding gene in the data bases. Besides the suppression of gene expression in the v-src transformed cells, its expression was also strongly suppressed in cells transformed by other oncogenes such as v-abl, v-fps, v-mos, v-sis, v-K-ras, and polyomavirus middle T, but not affected in cells transformed by human papillomavirus type 16 E6E7 and polyomavirus large T. We named the gene drs for a gene down-regulated by v-src.

摘要

我们分离出了一个新基因,它在正常大鼠细胞中表达,但在被v-src转化的细胞中完全被抑制。分子克隆的cDNA大小约为1.8 kb,包含一个由464个氨基酸残基组成的开放阅读框。DNA序列分析表明,数据库中没有相应的基因。除了在v-src转化细胞中基因表达受到抑制外,在被其他致癌基因如v-abl、v-fps、v-mos、v-sis、v-K-ras和多瘤病毒中间T转化的细胞中其表达也被强烈抑制,但在被人乳头瘤病毒16型E6E7和多瘤病毒大T转化的细胞中不受影响。我们将该基因命名为drs,即一个被v-src下调的基因。

相似文献

1
Isolation of a novel gene down-regulated by v-src.一个受v-src下调的新基因的分离
FEBS Lett. 1996 Mar 25;383(1-2):21-5. doi: 10.1016/0014-5793(96)00210-4.
2
Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture.鉴定出drm,一个新基因,其在转化细胞中的表达受到抑制,且在培养中能抑制正常细胞而非转化细胞的生长。
Mol Cell Biol. 1997 Aug;17(8):4801-10. doi: 10.1128/MCB.17.8.4801.
3
Molecular cloning and characterization of a cDNA showing tumor-suppressive activity in V-SRC-transformed 3Y1 rat fibroblasts.
Adv Enzyme Regul. 1994;34:247-55. doi: 10.1016/0065-2571(94)90019-1.
4
Molecular cloning and characterization of a cDNA showing negative regulation in v-src-transformed 3Y1 rat fibroblasts.一个在v-src转化的3Y1大鼠成纤维细胞中呈负调控的cDNA的分子克隆与特性分析
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2593-7. doi: 10.1073/pnas.90.7.2593.
5
Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras.一种新型促有丝分裂调节基因322的分离与鉴定,该基因在被src和ras转化的细胞中受到转录抑制。
Mol Cell Biol. 1995 May;15(5):2754-62. doi: 10.1128/MCB.15.5.2754.
6
Suppression in transformed avian fibroblasts of a gene (CO6) encoding a membrane protein related to mammalian potassium channel regulatory subunits.在转化的禽成纤维细胞中,一个编码与哺乳动物钾通道调节亚基相关的膜蛋白的基因(CO6)受到抑制。
Oncogene. 1997 Mar 6;14(9):1109-16. doi: 10.1038/sj.onc.1200930.
7
Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.通过cDNA消减技术分离转化抑制基因:核心蛋白聚糖抑制v-src和v-K-ras诱导的转化
J Virol. 2000 Jan;74(2):1008-13. doi: 10.1128/jvi.74.2.1008-1013.2000.
8
Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.从低转移性和高转移性劳斯肉瘤病毒转化的仓鼠细胞中分离出的v-src癌基因的两种新变体。
Virology. 1996 Feb 15;216(2):347-56. doi: 10.1006/viro.1996.0070.
9
Lamin A gene expression is specifically suppressed in v-src-transformed cells.核纤层蛋白A基因的表达在v-src转化的细胞中被特异性抑制。
FEBS Lett. 1992 Nov 9;312(2-3):165-8. doi: 10.1016/0014-5793(92)80927-9.
10
Suppression of anchorage-independent growth of human cancer cell lines by the drs gene.drs基因对人癌细胞系锚定非依赖性生长的抑制作用。
Oncogene. 1999 Aug 26;18(34):4777-87. doi: 10.1038/sj.onc.1202852.

引用本文的文献

1
Identifying potential signatures of immune cells in hepatocellular carcinoma using integrative bioinformatics approaches and machine-learning strategies.使用整合生物信息学方法和机器学习策略识别肝细胞癌中免疫细胞的潜在特征。
Immunol Res. 2025 Feb 4;73(1):46. doi: 10.1007/s12026-024-09585-3.
2
Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast Cancer.STAT3激活诱导SUSD2表达与HER2阳性乳腺癌的肿瘤复发相关。
Cells. 2024 Dec 28;14(1):19. doi: 10.3390/cells14010019.
3
SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma.
SRPX作为胶质母细胞瘤细胞外囊泡中的一种潜在肿瘤标志物出现。
Cancers (Basel). 2022 Apr 14;14(8):1984. doi: 10.3390/cancers14081984.
4
Genetic Programs Driving Oncogenic Transformation: Lessons from in Vitro Models.遗传程序驱动致癌转化:来自体外模型的教训。
Int J Mol Sci. 2019 Dec 12;20(24):6283. doi: 10.3390/ijms20246283.
5
A widespread peroxiredoxin-like domain present in tumor suppression- and progression-implicated proteins.普遍存在于肿瘤抑制和进展涉及的蛋白质中的过氧化物酶体相关域。
BMC Genomics. 2010 Oct 21;11:590. doi: 10.1186/1471-2164-11-590.
6
Pelota interacts with HAX1, EIF3G and SRPX and the resulting protein complexes are associated with the actin cytoskeleton.Pelota与HAX1、EIF3G和SRPX相互作用,所形成的蛋白质复合物与肌动蛋白细胞骨架相关。
BMC Cell Biol. 2010 Apr 20;11:28. doi: 10.1186/1471-2121-11-28.
7
Isolation of a novel mouse gene, mSVS-1/SUSD2, reversing tumorigenic phenotypes of cancer cells in vitro.一种新型小鼠基因mSVS-1/SUSD2的分离,该基因可在体外逆转癌细胞的致瘤表型。
Cancer Sci. 2007 Jun;98(6):900-8. doi: 10.1111/j.1349-7006.2007.00466.x. Epub 2007 Apr 12.
8
Down-regulation of drs mRNA in colorectal neoplasms.结直肠肿瘤中drs mRNA的下调。
Jpn J Cancer Res. 2002 Aug;93(8):888-93. doi: 10.1111/j.1349-7006.2002.tb01334.x.
9
Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.通过cDNA消减技术分离转化抑制基因:核心蛋白聚糖抑制v-src和v-K-ras诱导的转化
J Virol. 2000 Jan;74(2):1008-13. doi: 10.1128/jvi.74.2.1008-1013.2000.
10
Suppression of v-src transformation by the drs gene.drs基因对v-src转化的抑制作用。
J Virol. 1998 Mar;72(3):2532-7. doi: 10.1128/JVI.72.3.2532-2537.1998.